Document is current
Any future updates will be listed below
-
Authors
Singer, David https://orcid.org/0000-0001-8008-8003
La, Elizabeth M.
Graham, Jonathan
Molnar, Daniel
Grace, Mei
Poston, Sara
Verelst, Frederik
-
Funding
Funding for this research was provided by:
GlaxoSmithKline Biologicals
- License Information
-
More Information
Article History
Received: 9 July 2025
Accepted: 17 September 2025
First Online: 11 October 2025
Declarations
:
: David Singer, Elizabeth La, Sara Poston, and Frederik Verelst are employed by and hold financial equities in GSK. Daniel Molnar was employed by GSK at the time of the study. He is now employed by AstraZeneca. Jonathan Graham and Mei Grace are employed by RTI Health Solutions, which received funding from GSK for this study. The authors declare no other financial or non-financial relationships and activities.
: This research used publicly available data and data from previously conducted studies. It did not include any new experiments involving human participants or animals conducted by any of the authors and thus did not require institutional review board approval.
